Equities

AstraZeneca PLC

AZN:LSE

AstraZeneca PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)14,104.00
  • Today's Change124.00 / 0.89%
  • Shares traded3.06m
  • 1 Year change19.67%
  • Beta0.8596
Data delayed at least 20 minutes, as of Feb 06 2026 16:33 GMT.
More ▼

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue54,07345,81144,351
OPERATING EXPENSES
Cost of revenue total9,6588,0688,649
Selling, general and admin. expenses, total15,49514,64913,512
Depreciation/amortization3,8653,8664,094
Unusual expense(income)2,6807235,071
Other operating expenses, total16141(344)
Total operating expense44,07037,61840,594
Operating income10,0038,1933,757
Other, net(291)(457)(441)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes8,6916,8992,501
Provision for income taxes1,650938(792)
Net income after taxes7,0415,9613,293
Minority interest(6)(6)(5)
Net income before extra. Items7,0355,9553,288
Total extraordinary items------
Net income7,0355,9553,288
Inc.avail. to common excl. extra. Items7,0355,9553,288
Inc.avail. to common incl. extra. Items7,0355,9553,288
EPS RECONCILIATION
Basic/primary weighted average shares1,5501,5491,548
Basic/primary eps excl. extra items4.543.842.12
Basic/primary eps incl. extra items4.543.842.12
Dilution adjustment------
Diluted weighted average shares1,5631,5621,560
Diluted eps excl. extra items4.503.812.11
Diluted eps incl. extra items4.503.812.11
COMMON STOCK DIVIDENDS
DPS - common stock primary issue3.072.902.89
Gross dividend - common stock4,8064,4924,364
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental1,3911,132889
SUPPLEMENTAL INCOME
Depreciation, supplemental1,1421,0081,098
Total special items2,6807235,071
NORMALISED INCOME
Normalized income before taxes11,3717,6227,572
Effect of special items on income taxes1,3511,3532,850
Income tax excluding impact of special items3,0012,2912,058
Normalized income after tax8,3705,3315,514
Normalized income avail. to common8,3645,3255,509
Basic normalized EPS5.403.443.56
Diluted normalized EPS5.353.413.53
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.